TR200400812T3 - KanserÁtedavisiÁiçinÁretinoidÁreseptörÁligandlarınınÁveÁseçilenÁsitotoksikÁmaddelerinÁsinerjistikÁkombinasyonları - Google Patents

KanserÁtedavisiÁiçinÁretinoidÁreseptörÁligandlarınınÁveÁseçilenÁsitotoksikÁmaddelerinÁsinerjistikÁkombinasyonları

Info

Publication number
TR200400812T3
TR200400812T3 TR2004/00812T TR200400812T TR200400812T3 TR 200400812 T3 TR200400812 T3 TR 200400812T3 TR 2004/00812 T TR2004/00812 T TR 2004/00812T TR 200400812 T TR200400812 T TR 200400812T TR 200400812 T3 TR200400812 T3 TR 200400812T3
Authority
TR
Turkey
Prior art keywords
cytotoxic
rarα
cancer
reducing
treatment
Prior art date
Application number
TR2004/00812T
Other languages
English (en)
Turkish (tr)
Inventor
Sandrine�Valerie�Vivat@Hannah
V@�Matthew�Lorenzi
M@�Marco�Gottardis
Christopher�Fred�Zusi
Original Assignee
Bristol@Myers�Squibb�Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol@Myers�Squibb�Company filed Critical Bristol@Myers�Squibb�Company
Publication of TR200400812T3 publication Critical patent/TR200400812T3/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
TR2004/00812T 2001-03-22 2002-03-22 KanserÁtedavisiÁiçinÁretinoidÁreseptörÁligandlarınınÁveÁseçilenÁsitotoksikÁmaddelerinÁsinerjistikÁkombinasyonları TR200400812T3 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US27775401P 2001-03-22 2001-03-22

Publications (1)

Publication Number Publication Date
TR200400812T3 true TR200400812T3 (tr) 2004-07-21

Family

ID=23062213

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2004/00812T TR200400812T3 (tr) 2001-03-22 2002-03-22 KanserÁtedavisiÁiçinÁretinoidÁreseptörÁligandlarınınÁveÁseçilenÁsitotoksikÁmaddelerinÁsinerjistikÁkombinasyonları

Country Status (15)

Country Link
EP (1) EP1383491A2 (https=)
JP (1) JP2004528316A (https=)
KR (1) KR20030086314A (https=)
CN (1) CN1498105A (https=)
BR (1) BR0207681A (https=)
CA (1) CA2441335A1 (https=)
CZ (1) CZ20032540A3 (https=)
DE (1) DE02733871T1 (https=)
ES (1) ES2214985T1 (https=)
HU (1) HUP0400255A2 (https=)
IL (1) IL157358A0 (https=)
MX (1) MXPA03008403A (https=)
PL (1) PL368946A1 (https=)
TR (1) TR200400812T3 (https=)
WO (1) WO2002078620A2 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5113038B2 (ja) * 2006-03-23 2013-01-09 テムリック株式会社 癌治療用キットおよび癌治療用医薬組成物

Also Published As

Publication number Publication date
CN1498105A (zh) 2004-05-19
PL368946A1 (pl) 2005-04-04
IL157358A0 (en) 2004-02-19
BR0207681A (pt) 2004-07-27
HUP0400255A2 (hu) 2004-08-30
KR20030086314A (ko) 2003-11-07
DE02733871T1 (de) 2004-08-26
ES2214985T1 (es) 2004-10-01
JP2004528316A (ja) 2004-09-16
WO2002078620A2 (en) 2002-10-10
CA2441335A1 (en) 2002-10-10
CZ20032540A3 (cs) 2004-05-12
WO2002078620A3 (en) 2003-04-17
MXPA03008403A (es) 2004-01-29
EP1383491A2 (en) 2004-01-28

Similar Documents

Publication Publication Date Title
MXPA02011099A (es) Dispositivos de suministro para tratamiento de enfermedades vasculares.
MXPA03010085A (es) Composiciones y su uso en la hiperplasia.
BR0207961A (pt) Combinação de análogos da epotilona e agentes quimioterápicos para o tratamento de doenças proliferativas
MXPA05013642A (es) Composicion de un antagonista de vegf y un agente antiproliferativo y su uso para el tratamiento de cancer.
WO2002085299A3 (en) Therapeutic treatments using the direct application of antimicrobial metal compositions
IL163573A0 (en) Conjugates of therapeutic or cytotoxic agents and biologically active peptides
ATE533478T1 (de) Missbrauchssichere opioide mit transdermalen systemen
AR045179A1 (es) Uso de una combinacion de un inhibidor de la quinasa del receptor del factor de crecimiento epidermico y de agentes citotoxicos para el tratamiento e inhibicion del cancer
FR2869231B1 (fr) Composition therapeutique contenant au moins un derive de la pyrrolobenzodiazepine et la fludarabine
BR0107565A (pt) Formas de dosagem de benzimidazol substituìdo e método de emprego das mesmas
BRPI0411924A (pt) métodos e dispositivos para oclusão de lúmens de corpo e/ou para fornecimento de agentes terapêuticos
SG148202A1 (en) Quinazolinone compounds as anticancer agents
DE60031248D1 (de) Elektroaktive pore
BRPI0412975A (pt) espuma penetrante para uso farmacêutico
TW200626526A (en) Pharmaceutical compositions for the treatment of neoplasms
ATE307625T1 (de) Wirkstoffabgabesysteme zur behandlung von gefässerkrankungen
DE69932510D1 (de) Vaskularisierungsinhibitoren
TR200200359T2 (tr) Cgrp Antagonist'lerinin ve cgrp-release (Gevşeme)-Engelleyici Menopoza Bağlı Deri Kızarıklıklarında Kullanılması
ATE382356T1 (de) Pharmazeutische zusammensetzung enthaltend estetrolderivate und anwendung in der krebsbehandlung
AU2002347747A1 (en) Retinol derivatives, their use in the treatment of cancer and for potentiating the efficacy of other cytotoxic agents
MY137620A (en) Therapeutic treatment
AR033012A1 (es) Combinaciones antineoplasicas
ID24184A (id) Obat untuk perawatan disfungsi ereksi
CL2004000877A1 (es) Combinacion farmaceutica que comprende 8a) melatonina y agonistas de la melatonina, y nicotina y agonistas receptores de nicotina; kit farmaceutico, y; uso en el tratamiento de insomnio, dificultades cognitivas y dificultades de memoria; kit farmaceu
EA199900450A1 (ru) Агент, индуцирующий апоптоз